DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chang, T. K. H.
Right arrow Articles by Chen, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chang, T. K. H.
Right arrow Articles by Chen, J.

Vol. 31, Issue 1, 7-10, January 2003

SHORT COMMUNICATION
Constitutive Androstane Receptor and Pregnane X Receptor Gene Expression in Human Liver: Interindividual Variability and Correlation with CYP2B6 mRNA Levels

Thomas K. H. Chang, Stelvio M. Bandiera, and Jie Chen

Faculty of Pharmaceutical Sciences,
The University of British Columbia,
Vancouver, British Columbia, Canada

The constitutive androstane receptor (CAR) and pregnane X receptor (PXR) mediate the expression of mammalian cytochrome P450 (P450) 2B genes, including CYP2B6 in humans. Large interindividual differences exist in hepatic CYP2B6 expression, but the molecular basis for this variability is not well understood. In the present study, we developed real-time polymerase chain reaction methods to measure CYP2B6, CAR, and PXR mRNA expression and compared the levels in a panel of 12 individual human liver samples. The transcripts of CAR and CYP2B6 were present in all the samples analyzed, whereas those of PXR were detectable in all but one sample. A striking finding was the 240-fold interindividual variability in hepatic CAR mRNA levels, which was similar to the variability (278-fold) in CYP2B6 mRNA levels but greater than the 27-fold variability in PXR mRNA expression. Additional analysis revealed positive and statistically significant correlations between the mRNA levels of CAR and CYP2B6 (r2 = 0.63, p = 0.002), PXR and CYP2B6 (r2 = 0.75. p < 0.001), and CAR and PXR (r2 = 0.86, p < 0.001). In summary, substantial interindividual differences exist in hepatic CAR and, to a lesser extent, PXR gene expression. The variability in the abundance of these transcription factors may contribute to the large interindividual differences in CYP2B6 gene expression in human liver.


Copyright © 2003 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
A. J. Lau and T. K. H. Chang
Inhibition of Human CYP2B6-Catalyzed Bupropion Hydroxylation by Ginkgo biloba Extract: Effect of Terpene Trilactones and Flavonols
Drug Metab. Dispos., September 1, 2009; 37(9): 1931 - 1937.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Ellfolk, M. Norlin, K. Gyllensten, and K. Wikvall
Regulation of Human Vitamin D3 25-Hydroxylases in Dermal Fibroblasts and Prostate Cancer LNCaP Cells
Mol. Pharmacol., June 1, 2009; 75(6): 1392 - 1399.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
E. Y. H. Yeung, T. Sueyoshi, M. Negishi, and T. K. H. Chang
Identification of Ginkgo biloba as a Novel Activator of Pregnane X Receptor
Drug Metab. Dispos., November 1, 2008; 36(11): 2270 - 2276.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
J. Lamba, V. Lamba, S. Strom, R. Venkataramanan, and E. Schuetz
Novel Single Nucleotide Polymorphisms in the Promoter and Intron 1 of Human Pregnane X Receptor/NR1I2 and Their Association with CYP3A4 Expression
Drug Metab. Dispos., January 1, 2008; 36(1): 169 - 181.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
M. Wortham, M. Czerwinski, L. He, A. Parkinson, and Y.-J. Y. Wan
Expression of Constitutive Androstane Receptor, Hepatic Nuclear Factor 4{alpha}, and P450 Oxidoreductase Genes Determines Interindividual Variability in Basal Expression and Activity of a Broad Scope of Xenobiotic Metabolism Genes in the Human Liver
Drug Metab. Dispos., September 1, 2007; 35(9): 1700 - 1710.
[Abstract] [Full Text] [PDF]


Home page
J Clin PharmacolHome page
B. L. Urquhart, R. G. Tirona, and R. B. Kim
Nuclear Receptors and the Regulation of Drug-Metabolizing Enzymes and Drug Transporters: Implications for Interindividual Variability in Response to Drugs
J. Clin. Pharmacol., May 1, 2007; 47(5): 566 - 578.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Itoh, M. Nakajima, E. Higashi, R. Yoshida, K. Nagata, Y. Yamazoe, and T. Yokoi
Induction of Human CYP2A6 Is Mediated by the Pregnane X Receptor with Peroxisome Proliferator-Activated Receptor-{gamma} Coactivator 1{alpha}
J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 693 - 702.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
H. Sakai, H. Iwata, E.-Y. Kim, O. Tsydenova, N. Miyazaki, E. A. Petrov, V. B. Batoev, and S. Tanabe
Constitutive Androstane Receptor (CAR) as a Potential Sensing Biomarker of Persistent Organic Pollutants (POPs) in Aquatic Mammal: Molecular Characterization, Expression Level, and Ligand Profiling in Baikal Seal (Pusa sibirica)
Toxicol. Sci., November 1, 2006; 94(1): 57 - 70.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
S. J. Gardiner and E. J. Begg
Pharmacogenetics, Drug-Metabolizing Enzymes, and Clinical Practice
Pharmacol. Rev., September 1, 2006; 58(3): 521 - 590.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
C. A. Vyhlidal, R. Gaedigk, and J. S. Leeder
NUCLEAR RECEPTOR EXPRESSION IN FETAL AND PEDIATRIC LIVER: CORRELATION WITH CYP3A EXPRESSION
Drug Metab. Dispos., January 1, 2006; 34(1): 131 - 137.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
C. Tang, J. H. Lin, and A. Y. H. Lu
METABOLISM-BASED DRUG-DRUG INTERACTIONS: WHAT DETERMINES INDIVIDUAL VARIABILITY IN CYTOCHROME P450 INDUCTION?
Drug Metab. Dispos., May 1, 2005; 33(5): 603 - 613.
[Abstract] [Full Text] [PDF]


Home page
International Journal of ToxicologyHome page
D. Desaulniers, G. M. Cooke, K. Leingartner, K. Soumano, J. Cole, J. Yang, M. Wade, and A. Yagminas
Effects of Postnatal Exposure to a Mixture of Polychlorinated Biphenyls, p,p'-dichlorodiphenyltrichloroethane, and p-p'-dichlorodiphenyldichloroethene in Prepubertal and Adult Female Sprague-Dawley Rats
International Journal of Toxicology, March 1, 2005; 24(2): 111 - 127.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
J. Ramirez, F. Innocenti, E. G. Schuetz, D. A. Flockhart, M. V. Relling, R. Santucci, and M. J. Ratain
CYP2B6, CYP3A4, AND CYP2C19 ARE RESPONSIBLE FOR THE IN VITRO N-DEMETHYLATION OF MEPERIDINE IN HUMAN LIVER MICROSOMES
Drug Metab. Dispos., September 1, 2004; 32(9): 930 - 936.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. Jinno, T. Tanaka-Kagawa, N. Hanioka, S. Ishida, M. Saeki, A. Soyama, M. Itoda, T. Nishimura, Y. Saito, S. Ozawa, et al.
Identification of Novel Alternative Splice Variants of Human Constitutive Androstane Receptor and Characterization of Their Expression in the Liver
Mol. Pharmacol., March 1, 2004; 65(3): 496 - 502.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
E. G. Schuetz
Lessons from the CYP3A4 Promoter
Mol. Pharmacol., February 1, 2004; 65(2): 279 - 281.
[Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
C. Handschin and U. A. Meyer
Induction of Drug Metabolism: The Role of Nuclear Receptors
Pharmacol. Rev., December 1, 2003; 55(4): 649 - 673.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
V. Lamba, J. Lamba, K. Yasuda, S. Strom, J. Davila, M. L. Hancock, J. D. Fackenthal, P. K. Rogan, B. Ring, S. A. Wrighton, et al.
Hepatic CYP2B6 Expression: Gender and Ethnic Differences and Relationship to CYP2B6 Genotype and CAR (Constitutive Androstane Receptor) Expression
J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 906 - 922.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. A. Ward, J. C. Gorski, D. R. Jones, S. D. Hall, D. A. Flockhart, and Z. Desta
The Cytochrome P450 2B6 (CYP2B6) Is the Main Catalyst of Efavirenz Primary and Secondary Metabolism: Implication for HIV/AIDS Therapy and Utility of Efavirenz as a Substrate Marker of CYP2B6 Catalytic Activity
J. Pharmacol. Exp. Ther., July 1, 2003; 306(1): 287 - 300.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. S. Auerbach, R. Ramsden, M. A. Stoner, C. Verlinde, C. Hassett, and C. J. Omiecinski
Alternatively spliced isoforms of the human constitutive androstane receptor
Nucleic Acids Res., June 15, 2003; 31(12): 3194 - 3207.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
L. M. Hesse and M. H. Court
Quantitation of CYP2B6, Constitutive Androstane Receptor, and Pregnane X Receptor mRNA levels
Drug Metab. Dispos., May 1, 2003; 31(5): 685 - 685.
[Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
T. K. H. Chang, S. M. Bandiera, and J. Chen
Response to Letter to the Editor
Drug Metab. Dispos., May 1, 2003; 31(5): 686 - 686.
[Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.